Depression treatment for Lantana — measurement-based, 18 minutes away.
A specialist outpatient program for clients in Lantana. PHP, IOP, in-house psychiatry, sober-living network, family programming. Same admissions team, 24/7.
Start the conversation Or call directly — (561) 464-4077Local options exist. This is the clinical specialist.
RECO Health's Delray Beach campus is 18 minutes from Lantana down Federal Highway — the closest clinically-led PHP and IOP depression program north of Broward. In-house psychiatry, weekly PHQ-9 tracking, and a defined escalation pathway to rTMS or IV ketamine when two antidepressant trials fail. Every treatment plan is DSM-5-TR anchored and measurement-driven, not impression-driven.
Lantana sits on the Intracoastal between Delray Beach and West Palm Beach, with Hypoluxo Island, Manalapan, and Ocean Ridge tucked behind it along A1A. For residents of these barrier-island communities and Old Town Lantana proper, RECO Health’s Delray Beach campus is 11 miles south — an 18-minute drive down Federal Highway, often faster on A1A when the coast road is clear. RECO offers the closest clinically-led PHP and IOP depression treatment program north of Broward, with in-house psychiatry, evidence-based psychotherapy, and interventional options when the first two lines don’t get a client to remission.
Diagnostic formulation and severity staging
Depression is not a single disease, and the initial evaluation is built to distinguish it from what it looks like. A RECO psychiatrist works through DSM-5-TR criteria to separate major depressive disorder from persistent depressive disorder, bipolar II depression, adjustment disorder with depressed mood, and depression secondary to a general medical condition or substance use. Missing an underlying bipolar diathesis and starting an SSRI can precipitate a mixed or manic episode; ruling it out with a careful history and an MDQ is not optional.
Severity is anchored to instruments, not impression. The PHQ-9 stages depressive severity from mild (5-9) through moderate (10-14), moderately severe (15-19), and severe (20-27), and is repeated weekly to track response. The C-SSRS captures suicidal ideation, intent, plan, and behavior at every visit. Medical contributors — hypothyroidism, B12 or folate deficiency, low vitamin D, undertreated obstructive sleep apnea — are ruled out with labs at intake rather than assumed absent.
Level of care follows severity. Partial Hospitalization (PHP) is indicated for severe MDD, acute suicidal ideation without imminent plan, or functional collapse. Intensive Outpatient (IOP) fits moderate presentations where the client can function outside of clinic hours. That distinction is made by the admissions psychiatrist against ASAM Criteria dimensions and clinical judgment, not by client preference or insurance convenience.
Pharmacology sequenced by evidence, not habit
First-line pharmacotherapy for major depression is an SSRI — sertraline, escitalopram — or an SNRI — venlafaxine, duloxetine — titrated to therapeutic dose and given four to six weeks at that dose before response is declared. A common failure mode elsewhere is labeling a medication a failure at subtherapeutic dose or four weeks in; RECO does not.
Partial responders — PHQ-9 improved but not remitted — are augmented rather than switched. STAR*D and subsequent trials support augmentation with aripiprazole (2-15 mg), lithium (with serum level targeting 0.6-0.8 mEq/L), or bupropion added to an SSRI. Quetiapine XR is an option where sedation and anxious distress coexist; olanzapine-fluoxetine combination is reserved for select refractory cases. Non-responders are switched to a mechanistically distinct agent rather than a within-class swap.
Treatment-resistant depression is defined precisely: two adequate antidepressant trials at therapeutic dose and duration without remission. At that point RECO does not cycle a fifth antidepressant. Clients are staged for interventional care — rTMS, IV ketamine, or esketamine — with the choice driven by the suicidality timeline, insurance eligibility, and comorbidity. Every medication decision is documented alongside the PHQ-9 trajectory so any subsequent clinician can see the arc.
Behavioral therapy modalities with evidence for depression
Not every therapy called “talk therapy” has evidence for depression. RECO’s therapists deliver the modalities that do, to protocol, and document which protocol they are running at what session number.
Cognitive Behavioral Therapy for depression targets the cognitive distortions — catastrophizing, all-or-nothing thinking, personalization, mind-reading — that maintain low mood, pairing cognitive restructuring with behavioral experiments. Behavioral Activation treats depression as a reinforcement problem: withdrawal reduces access to reward and mastery, which deepens withdrawal. BA re-schedules those activities against the spiral. Interpersonal Therapy is deployed where the depressive episode is anchored to grief, a role transition, or an ongoing interpersonal dispute.
For clients whose depression sits on top of trauma, EMDR or Cognitive Processing Therapy is layered in — the depression rarely lifts durably while underlying PTSD is untouched. Acceptance and Commitment Therapy is used where rumination and experiential avoidance dominate. Motivational Interviewing is threaded through when a co-occurring substance use disorder undermines engagement. DBT skills — distress tolerance, emotion regulation — are added where impulsivity or self-harm is prominent.
Escalation pathway when medication and therapy aren’t enough
Roughly a third of clients with major depression will not achieve remission with two adequate antidepressant trials. RECO’s escalation pathway is defined in advance rather than improvised after months of drift.
Repetitive Transcranial Magnetic Stimulation (rTMS) is the first interventional step for insurance-eligible TRD. The standard protocol delivers 10 Hz stimulation over the left dorsolateral prefrontal cortex at 120% of motor threshold — 3,000 pulses per session, five days per week for six weeks (36 sessions), followed by a six-session taper. Response rates in TRD approach 50-60% and remission rates 30-40% in registrational data. RECO’s TMS suite is on the Delray campus, so Lantana clients continue at the same site as their outpatient care.
IV ketamine (0.5 mg/kg over 40 minutes, six-infusion induction across two to three weeks) is used where suicidality or functional collapse does not allow a six-week TMS course, or where TMS is not insurance-eligible. Esketamine (Spravato) is used where a REMS-monitored intranasal protocol is preferred and covered — the two-hour post-dose monitoring window is built into the schedule. Escalation is triggered by PHQ-9 non-response on a defined timeline, not by a clinician’s mood impression at follow-up.
What to expect on your first visit
Intake is a 60 to 90 minute psychiatric evaluation covering psychiatric history, medical history, current medication list, family psychiatric history, substance use screen (AUDIT and DAST), and current psychosocial stressors. Rating scales — PHQ-9, GAD-7, C-SSRS, and an MDQ — are administered at the visit and become the baseline against which all subsequent care is measured.
If baseline labs have not been drawn in the last 60 days, RECO draws TSH, CBC, CMP, B12, folate, and vitamin D on-site. The psychiatrist and lead therapist formulate a working diagnosis and initial treatment plan before the client leaves the building — level of care, medication starting point, therapy modality, ancillary services. Clients leave with a written plan, prescriptions if clinically indicated, and a scheduled second visit within 72 hours.
Insurance and admissions from Lantana
RECO Health is in-network with most major commercial payers, including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans. The admissions team runs a verification of benefits before the intake and quotes the client’s specific deductible, co-insurance, and out-of-pocket maximum in dollars — not vague “your plan covers it” language.
For Lantana residents, the drive to RECO’s Delray Beach campus is 11 miles down Federal Highway or A1A — 18 minutes without traffic. PHP clients attend five days a week, six hours per day; IOP clients attend three days a week, three hours per session, with morning and evening tracks so clients can hold employment or family responsibilities alongside structured care.
Serving residents of: Hypoluxo Island, Manalapan, Ocean Ridge, Old Town Lantana.
If it's any of these, we can help.
From Lantana callers, most asked.
Does insurance cover depression treatment for Lantana residents?
How long does a depression treatment program at RECO take?
What happens on the first visit?
How does rTMS work and who is it for?
How do I get to RECO Health from Lantana?
Can my family be involved in treatment?
Other lantana-area communities we serve.
Confidential. No commitment.
Tell us a little and a real human from admissions will call you back. We verify insurance benefits within minutes and tell you honestly whether RECO Health is the right fit — including if we should refer you elsewhere.


